BACKGROUND: Citrox is a formulation of soluble bioflavonoids obtained from citrus fruits. The non-toxic and antimicrobial properties of natural bioflavonoids are well documented, and consequently there has been interest in the therapeutic application of these substances. OBJECTIVE: To determine the antimicrobial activity of two Citrox formulations (BC30 and MDC30) with different bioflavonoid combinations against a range of oral microorganisms. METHODS: The antimicrobial activity of both formulations was tested against 14 bacterial species and six Candida species. The two Citrox formulations (dilution range 0.007-8% v/v) were firstly evaluated by determining the in vitro Minimal Inhibitory Concentration (MIC) against planktonic microorganisms in a broth microdilution assay. Secondly, the ability of the same serial dilutions to inhibit microbial growth was assessed in a modified microtitre biofilm assay. RESULTS: Both Citrox formulations exhibited antimicrobial activity. The BC30 formulation demonstrated greater activity than MDC30 and significantly inhibited growth of all bacterial species and most candidal species tested at a concentration of 1% (v/v) in both the broth and the biofilm assay. CONCLUSION: Bioflavonoid preparations of Citrox have a broad-spectrum of antimicrobial activity against oral microorganisms, and as such have the potential to be used within therapeutic preparations for the control of the oral microflora.
BACKGROUND:Citrox is a formulation of soluble bioflavonoids obtained from citrus fruits. The non-toxic and antimicrobial properties of natural bioflavonoids are well documented, and consequently there has been interest in the therapeutic application of these substances. OBJECTIVE: To determine the antimicrobial activity of two Citrox formulations (BC30 and MDC30) with different bioflavonoid combinations against a range of oral microorganisms. METHODS: The antimicrobial activity of both formulations was tested against 14 bacterial species and six Candida species. The two Citrox formulations (dilution range 0.007-8% v/v) were firstly evaluated by determining the in vitro Minimal Inhibitory Concentration (MIC) against planktonic microorganisms in a broth microdilution assay. Secondly, the ability of the same serial dilutions to inhibit microbial growth was assessed in a modified microtitre biofilm assay. RESULTS: Both Citrox formulations exhibited antimicrobial activity. The BC30 formulation demonstrated greater activity than MDC30 and significantly inhibited growth of all bacterial species and most candidal species tested at a concentration of 1% (v/v) in both the broth and the biofilm assay. CONCLUSION:Bioflavonoid preparations of Citrox have a broad-spectrum of antimicrobial activity against oral microorganisms, and as such have the potential to be used within therapeutic preparations for the control of the oral microflora.
Authors: Sladjana Malic; Rachael P C Jordan; Mark G J Waters; David J Stickler; David W Williams Journal: Antimicrob Agents Chemother Date: 2013-11-18 Impact factor: 5.191
Authors: Emma Louise Board-Davies; William Rhys-Williams; Daniel Hynes; David Williams; Damian Joseph John Farnell; William Love Journal: Front Cell Infect Microbiol Date: 2022-06-30 Impact factor: 6.073
Authors: S Hogan; M Zapotoczna; N T Stevens; H Humphreys; J P O'Gara; E O'Neill Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Florence Carrouel; Maria Pia Conte; Julian Fisher; Lucio Souza Gonçalves; Claude Dussart; Juan Carlos Llodra; Denis Bourgeois Journal: J Clin Med Date: 2020-04-15 Impact factor: 4.241
Authors: Pune N Paqué; Patrick R Schmidlin; Daniel B Wiedemeier; Florian J Wegehaupt; Phoebe D Burrer; Philipp Körner; Shengjile Deari; Michel-Angelo Sciotti; Thomas Attin Journal: Int J Environ Res Public Health Date: 2021-01-19 Impact factor: 3.390
Authors: F Carrouel; L S Gonçalves; M P Conte; G Campus; J Fisher; L Fraticelli; E Gadea-Deschamps; L Ottolenghi; D Bourgeois Journal: J Dent Res Date: 2020-10-22 Impact factor: 6.116